PortfoliosLab logo
NVCR vs. COST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NVCR and COST is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

NVCR vs. COST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NovoCure Limited (NVCR) and Costco Wholesale Corporation (COST). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

NVCR:

0.10

COST:

1.39

Sortino Ratio

NVCR:

0.95

COST:

1.96

Omega Ratio

NVCR:

1.11

COST:

1.27

Calmar Ratio

NVCR:

0.13

COST:

1.81

Martin Ratio

NVCR:

0.40

COST:

5.32

Ulcer Index

NVCR:

29.90%

COST:

5.89%

Daily Std Dev

NVCR:

81.54%

COST:

21.91%

Max Drawdown

NVCR:

-95.07%

COST:

-53.39%

Current Drawdown

NVCR:

-92.30%

COST:

-6.26%

Fundamentals

Market Cap

NVCR:

$1.94B

COST:

$447.27B

EPS

NVCR:

-$1.51

COST:

$17.12

PEG Ratio

NVCR:

-0.47

COST:

5.33

PS Ratio

NVCR:

3.13

COST:

1.69

PB Ratio

NVCR:

5.35

COST:

17.47

Total Revenue (TTM)

NVCR:

$621.71M

COST:

$264.09B

Gross Profit (TTM)

NVCR:

$479.70M

COST:

$35.11B

EBITDA (TTM)

NVCR:

-$105.45M

COST:

$11.25B

Returns By Period

In the year-to-date period, NVCR achieves a -41.68% return, which is significantly lower than COST's 10.29% return.


NVCR

YTD

-41.68%

1M

8.08%

6M

-0.34%

1Y

5.53%

5Y*

-23.18%

10Y*

N/A

COST

YTD

10.29%

1M

4.68%

6M

7.07%

1Y

28.72%

5Y*

28.78%

10Y*

23.77%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NVCR vs. COST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVCR
The Risk-Adjusted Performance Rank of NVCR is 5959
Overall Rank
The Sharpe Ratio Rank of NVCR is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of NVCR is 6565
Sortino Ratio Rank
The Omega Ratio Rank of NVCR is 6161
Omega Ratio Rank
The Calmar Ratio Rank of NVCR is 5858
Calmar Ratio Rank
The Martin Ratio Rank of NVCR is 5757
Martin Ratio Rank

COST
The Risk-Adjusted Performance Rank of COST is 8888
Overall Rank
The Sharpe Ratio Rank of COST is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of COST is 8585
Sortino Ratio Rank
The Omega Ratio Rank of COST is 8484
Omega Ratio Rank
The Calmar Ratio Rank of COST is 9292
Calmar Ratio Rank
The Martin Ratio Rank of COST is 8787
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NVCR vs. COST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for NovoCure Limited (NVCR) and Costco Wholesale Corporation (COST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current NVCR Sharpe Ratio is 0.10, which is lower than the COST Sharpe Ratio of 1.39. The chart below compares the historical Sharpe Ratios of NVCR and COST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

NVCR vs. COST - Dividend Comparison

NVCR has not paid dividends to shareholders, while COST's dividend yield for the trailing twelve months is around 0.47%.


TTM20242023202220212020201920182017201620152014
NVCR
NovoCure Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
COST
Costco Wholesale Corporation
0.47%0.49%2.87%0.76%0.54%3.38%0.86%1.08%4.81%1.09%4.06%0.97%

Drawdowns

NVCR vs. COST - Drawdown Comparison

The maximum NVCR drawdown since its inception was -95.07%, which is greater than COST's maximum drawdown of -53.39%. Use the drawdown chart below to compare losses from any high point for NVCR and COST. For additional features, visit the drawdowns tool.


Loading data...

Volatility

NVCR vs. COST - Volatility Comparison

NovoCure Limited (NVCR) has a higher volatility of 16.62% compared to Costco Wholesale Corporation (COST) at 5.91%. This indicates that NVCR's price experiences larger fluctuations and is considered to be riskier than COST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

NVCR vs. COST - Financials Comparison

This section allows you to compare key financial metrics between NovoCure Limited and Costco Wholesale Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20212022202320242025
154.99M
63.72B
(NVCR) Total Revenue
(COST) Total Revenue
Values in USD except per share items

NVCR vs. COST - Profitability Comparison

The chart below illustrates the profitability comparison between NovoCure Limited and Costco Wholesale Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%20212022202320242025
75.2%
15.1%
(NVCR) Gross Margin
(COST) Gross Margin
NVCR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, NovoCure Limited reported a gross profit of 116.47M and revenue of 154.99M. Therefore, the gross margin over that period was 75.2%.

COST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported a gross profit of 9.61B and revenue of 63.72B. Therefore, the gross margin over that period was 15.1%.

NVCR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, NovoCure Limited reported an operating income of -37.87M and revenue of 154.99M, resulting in an operating margin of -24.4%.

COST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported an operating income of 2.32B and revenue of 63.72B, resulting in an operating margin of 3.6%.

NVCR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, NovoCure Limited reported a net income of -34.32M and revenue of 154.99M, resulting in a net margin of -22.1%.

COST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported a net income of 1.79B and revenue of 63.72B, resulting in a net margin of 2.8%.